{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:17:43Z","timestamp":1783397863399,"version":"3.54.6"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101168","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:42:41Z","timestamp":1776181361000},"page":"101168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Outcomes of stereotactic body radiotherapy for supraclavicular lymph node metastasis among patients with metastatic prostate cancer"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1091-8615","authenticated-orcid":false,"given":"Andres L.","family":"Frias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Stish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-853X","authenticated-orcid":false,"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny W.","family":"Merrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0363-8002","authenticated-orcid":false,"given":"Jessica M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Waddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8256-1706","authenticated-orcid":false,"given":"Kristi L.","family":"Sammon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6892-3270","authenticated-orcid":false,"given":"Shelly B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-2836","authenticated-orcid":false,"given":"Daniel S.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-0239","authenticated-orcid":false,"given":"Jacob J.","family":"Orme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J.","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene D.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8288-1096","authenticated-orcid":false,"given":"Brian J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2026.101168_b0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2017.07.011","article-title":"Prostate cancer\u2013specific PET radiotracers: a review on the clinical utility in recurrent disease","volume":"8","author":"Evans","year":"2018","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101168_b0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bco2.308","article-title":"Low PSA radiographic disease progression on C11-choline PET","volume":"5","author":"Mahmoud","year":"2023","journal-title":"BJUI Compass"},{"issue":"5","key":"10.1016\/j.ctro.2026.101168_b0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101168_b0020","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"issue":"10185","key":"10.1016\/j.ctro.2026.101168_b0025","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomized, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ctro.2026.101168_b0030","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s00261-022-03487-4","article-title":"What's in a node? The clinical and radiologic significance of Virchow\u2019s node","volume":"47","author":"Adler","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"10.1016\/j.ctro.2026.101168_b0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2214\/AJR.11.7533","article-title":"Atypical metastases from prostate cancer: 10-year experience at a single institution","volume":"199","author":"Vinjamoori","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ctro.2026.101168_b0040","doi-asserted-by":"crossref","unstructured":"Ascio NM, Qureshi A, Banayan E, Asarian A, Genato R, Xiao P. Supraclavicular metastasis from prostate cancer: unusual case and literature review. J Surg Case Rep. 2023;2023(3):rjad091. doi:10.1093\/jscr\/rjad091.","DOI":"10.1093\/jscr\/rjad091"},{"issue":"3","key":"10.1016\/j.ctro.2026.101168_b0045","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1097\/RLU.0000000000000708","article-title":"Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET\/CT","volume":"40","author":"Pinaquy","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.ctro.2026.101168_b0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2016.08.055","article-title":"Identification of site-specific recurrence following primary radiation therapy for prostate cancer using C-11 choline PET\/CT: a nomogram for predicting extrapelvic disease","volume":"71","author":"Parker","year":"2017","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101168_b0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(25)00197-4","article-title":"Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V\u2013STORM): a phase 2, open-label, randomized controlled trial","volume":"26","author":"Ost","year":"2025","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2026.101168_b0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-095560","article-title":"Pelvis or involved node treatment: eradicating recurrence in prostate cancer (POINTER-PC) \u2013 study protocol paper for a phase III multicentre, open-label randomized controlled trial","volume":"14","author":"Slevin","year":"2024","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.ctro.2026.101168_b0065","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamaoncol.2023.0161","article-title":"Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: the EXTEND phase 2 randomized clinical trial","volume":"9","author":"Tang","year":"2023","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101168_b0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1470-2045(24)00730-7","article-title":"ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomized, open-label, phase 2 clinical trial","volume":"26","author":"Marvaso","year":"2025","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101168_b0075","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2019.07.009","article-title":"Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy","volume":"76","author":"De Bleser","year":"2019","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101168_b0080","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ijrobp.2022.11.012","article-title":"Hypofractionated stereotactic radiation therapy dosimetric tolerances for the inferior aspect of the brachial plexus: a systematic review","volume":"118","author":"Milano","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101168_b0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2026.101168_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.semradonc.2017.02.001","article-title":"Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy","volume":"27","author":"Pollom","year":"2017","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101168_b0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.ctro.2026.101168_b0100","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ijrobp.2009.02.027","article-title":"Chest wall volume receiving >30 Gy predicts risk of severe pain and\/or rib fracture after lung stereotactic body radiotherapy","volume":"76","author":"Dunlap","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:45:14Z","timestamp":1783395914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"alternative-id":["S2405630826000637"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101168","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of stereotactic body radiotherapy for supraclavicular lymph node metastasis among patients with metastatic prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101168"}}